Giusy Gentilcore

1.8k total citations
31 papers, 1.2k citations indexed

About

Giusy Gentilcore is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Giusy Gentilcore has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Giusy Gentilcore's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Giusy Gentilcore is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Giusy Gentilcore collaborates with scholars based in Italy, Sweden and Qatar. Giusy Gentilcore's co-authors include Paolo A. Ascierto, Giuseppe Palmieri, Jean‐Charles Grivel, Gabriele Madonna, Chiara Cugno, Rita Calzone, Selma Maacha, Shana Jacob, Johan Hansson and Nicola Mozzillo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Giusy Gentilcore

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giusy Gentilcore Italy 15 526 484 478 251 151 31 1.2k
Eva M. Garrido‐Martín Spain 19 545 1.0× 615 1.3× 617 1.3× 182 0.7× 164 1.1× 36 1.6k
Xueli Fan United States 16 467 0.9× 482 1.0× 503 1.1× 161 0.6× 182 1.2× 25 1.5k
Jules Gadiot Netherlands 14 641 1.2× 483 1.0× 461 1.0× 123 0.5× 139 0.9× 21 1.1k
Cornelia Rudolph Germany 18 523 1.0× 1.4k 2.9× 287 0.6× 215 0.9× 227 1.5× 41 2.1k
Yingzi Ge Germany 16 600 1.1× 419 0.9× 665 1.4× 150 0.6× 70 0.5× 22 1.2k
Linda N. Liu United States 12 747 1.4× 609 1.3× 672 1.4× 62 0.2× 156 1.0× 20 1.4k
W Zhang United States 13 437 0.8× 550 1.1× 225 0.5× 90 0.4× 259 1.7× 19 1.0k
Hong Xin United States 18 490 0.9× 657 1.4× 319 0.7× 487 1.9× 338 2.2× 33 1.5k
Paula Yeng Po Lam Singapore 19 419 0.8× 927 1.9× 171 0.4× 401 1.6× 309 2.0× 49 1.6k
Yolanda Campos‐Martín Spain 16 311 0.6× 568 1.2× 297 0.6× 166 0.7× 350 2.3× 25 1.2k

Countries citing papers authored by Giusy Gentilcore

Since Specialization
Citations

This map shows the geographic impact of Giusy Gentilcore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giusy Gentilcore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giusy Gentilcore more than expected).

Fields of papers citing papers by Giusy Gentilcore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giusy Gentilcore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giusy Gentilcore. The network helps show where Giusy Gentilcore may publish in the future.

Co-authorship network of co-authors of Giusy Gentilcore

This figure shows the co-authorship network connecting the top 25 collaborators of Giusy Gentilcore. A scholar is included among the top collaborators of Giusy Gentilcore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giusy Gentilcore. Giusy Gentilcore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al-Mohannadi, Anjud, et al.. (2025). Flow Cytometry Evaluation of Blood-Cell-Bound Surface FVIII in Hemophilia A and Thrombosis. PubMed. 14(2). 73–73. 1 indexed citations
2.
Murugesan, Selvasankar, Mohamed Nadhir Djekidel, Annalisa Terranegra, et al.. (2025). Distinctive blood and salivary proteomics signatures in Qatari individuals at high risk for cardiovascular disease. Scientific Reports. 15(1). 4056–4056. 3 indexed citations
3.
Murugesan, Selvasankar, Giusy Gentilcore, Jean‐Charles Grivel, et al.. (2024). Immunoglobulin-coating patterns reveal altered humoral responses to gut bacteria in pediatric cow milk allergies. Journal of Translational Medicine. 22(1). 1021–1021. 2 indexed citations
4.
Murugesan, Selvasankar, et al.. (2024). Microbial and proteomic signatures of type 2 diabetes in an Arab population. Journal of Translational Medicine. 22(1). 1132–1132. 1 indexed citations
5.
Al-Mohannadi, Anjud, Giusy Gentilcore, Suruchi Mohan, et al.. (2022). CD14+/CD31+ monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII. Blood Advances. 7(5). 697–711. 2 indexed citations
6.
Al-Mohannadi, Anjud, Christophe M. Raynaud, Giusy Gentilcore, et al.. (2019). Flow-Cytometry Platform for Intracellular Detection of FVIII in Blood Cells: A New Tool to Assess Gene Therapy Efficiency for Hemophilia A. Molecular Therapy — Methods & Clinical Development. 17. 1–12. 5 indexed citations
7.
Camerlingo, Rosa, Maria Vincenza Carriero, Giuseppe Pirozzi, et al.. (2018). Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells. International Journal of Oncology. 53(3). 1149–1159. 20 indexed citations
8.
Palma, Marzia, Lotta Hansson, Lars Adamson, et al.. (2018). Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients. European Journal Of Haematology. 101(1). 68–77. 13 indexed citations
9.
Palma, Marzia, Giusy Gentilcore, Fariba Mozaffari, et al.. (2016). T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers. Haematologica. 102(3). 562–572. 130 indexed citations
10.
Mozzillo, Nicola, Ester Simeone, Marcello Curvietto, et al.. (2015). Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy. OncoImmunology. 4(6). e1008842–e1008842. 55 indexed citations
11.
Pittari, Gianfranco, Perla Filippini, Giusy Gentilcore, Jean‐Charles Grivel, & Sergio Rutella. (2015). Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies. Frontiers in Immunology. 6. 230–230. 60 indexed citations
12.
Ishikawa, Taichi, Zenebech Wondimu, Giusy Gentilcore, et al.. (2014). Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146). Matrix Biology. 38. 69–83. 56 indexed citations
13.
Coaña, Yago Pico de, Isabel Poschke, Giusy Gentilcore, et al.. (2013). Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production. Cancer Immunology Research. 1(3). 158–162. 110 indexed citations
14.
Queirolo, Paola, Anna Morabito, Stefania Laurent, et al.. (2013). Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study. Cancer Investigation. 31(5). 336–345. 44 indexed citations
15.
Ridolfi, Laura, Massimiliano Petrini, Anna Maria Granato, et al.. (2013). Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients. Journal of Translational Medicine. 11(1). 135–135. 58 indexed citations
16.
Cantile, Monica, Giosuè Scognamiglio, Giusy Gentilcore, et al.. (2012). Increased HOX C13 expression in metastatic melanoma progression. Journal of Translational Medicine. 10(1). 91–91. 37 indexed citations
17.
Madonna, Gabriele, et al.. (2012). NF-κB as potential target in the treatment of melanoma. Journal of Translational Medicine. 10(1). 53–53. 116 indexed citations
18.
Simeone, Ester, Giusy Gentilcore, Alessandro Esposito, et al.. (2011). 9322 POSTER Immunological and Biological Changes and Their Correlation With Clinical Response and Survival During Ipilimumab in Metastatic Melanoma Compassionate Use Program. European Journal of Cancer. 47. S658–S659. 3 indexed citations
19.
Palmieri, Giuseppe, Mariaelena Capone, Maria Libera Ascierto, et al.. (2009). Main roads to melanoma. Journal of Translational Medicine. 7(1). 86–86. 129 indexed citations
20.
Ianaro, Angela, Giuseppe Belardo, Maria Napolitano, et al.. (2008). NEMO-binding domain peptide inhibits proliferation of human melanoma cells. Cancer Letters. 274(2). 331–336. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva M. Garrido‐Martín Breakdown of academic impact, for papers by Xueli Fan Breakdown of academic impact, for papers by Jules Gadiot Breakdown of academic impact, for papers by Cornelia Rudolph Breakdown of academic impact, for papers by Yingzi Ge Breakdown of academic impact, for papers by Linda N. Liu Breakdown of academic impact, for papers by W Zhang Breakdown of academic impact, for papers by Hong Xin Breakdown of academic impact, for papers by Paula Yeng Po Lam Breakdown of academic impact, for papers by Yolanda Campos‐Martín
Rankless by CCL
2026